Projected Income Statement: CSL Limited

Forecast Balance Sheet: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 -779 10,679 10,526 8,981 9,383 9,182 8,885 8,406
Change - 1,470.86% -1.43% -14.68% 4.48% -2.14% -3.23% -5.39%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 1,079 1,228 849 636 646 912.4 1,013 1,036
Change - 13.83% -30.86% -25.09% 1.57% 41.23% 11% 2.28%
Free Cash Flow (FCF) 1 1,550 1,373 1,915 2,925 2,866 3,129 2,940 3,097
Change - -11.41% 39.48% 52.74% -2.02% 9.18% -6.04% 5.35%
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CSL Limited

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 34.04% 29.3% 32.09% 33.11% 28.09% 32.25% 32.62% 32.89%
EBIT Margin (%) 27.72% 23.06% 25.76% 28.72% 29.25% 27.7% 28.13% 28.35%
EBT Margin (%) 26.32% 20.01% 22.8% 23.94% -25.87% 23.44% 25.16% 25.48%
Net margin (%) 21.35% 16.48% 17.85% 19.3% -16.33% 17.91% 19.34% 19.72%
FCF margin (%) 14.67% 10.32% 12.94% 18.8% 18.14% 19.85% 18% 18.18%
FCF / Net Income (%) 68.74% 62.58% 72.48% 97.44% -111.13% 110.83% 93.07% 92.18%

Profitability

        
ROA 9.7% 6.79% 7.12% 7.75% -7.06% 10.31% 10.49% 10.65%
ROE 19.64% 14.45% 15.94% 16.36% -15.11% 19.11% 18.78% 18.51%

Financial Health

        
Leverage (Debt/EBITDA) - 2.74x 2.22x 1.74x 2.11x 1.81x 1.67x 1.5x
Debt / Free cash flow - 7.78x 5.5x 3.07x 3.27x 2.93x 3.02x 2.71x

Capital Intensity

        
CAPEX / Current Assets (%) 10.21% 9.23% 5.74% 4.09% 4.09% 5.79% 6.2% 6.08%
CAPEX / EBITDA (%) 30% 31.49% 17.87% 12.35% 14.56% 17.94% 19.01% 18.48%
CAPEX / FCF (%) 69.6% 89.44% 44.33% 21.74% 22.54% 29.16% 34.45% 33.44%

Items per share

        
Cash flow per share 1 5.592 5.375 5.697 7.324 7.287 7.369 7.988 8.45
Change - -3.87% 5.98% 28.56% -0.51% 1.13% 8.4% 5.78%
Dividend per Share 1 2.22 2.36 2.64 2.92 2.92 2.998 3.188 3.419
Change - 6.31% 11.86% 10.61% 0% 2.68% 6.34% 7.23%
Book Value Per Share 1 30.26 32.73 35.93 39.93 30.9 33.7 36.67 40.17
Change - 8.14% 9.79% 11.14% -22.62% 9.07% 8.82% 9.53%
EPS 1 4.8 4.53 5.45 6.17 -5.35 6.073 6.717 7.059
Change - -5.62% 20.31% 13.21% -186.71% 213.52% 10.6% 5.09%
Nbr of stocks (in thousands) 481,706 482,372 483,253 484,212 478,912 478,912 478,912 478,912
Announcement Date 16/08/22 14/08/23 12/08/24 18/08/25 17/08/26 - - -
1USD
Estimates
2027 *2028 *
P/E 20.9x 18.9x
PBR 3.77x 3.47x
EV / Sales 4.44x 4.27x
Yield 2.36% 2.51%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
127.15USD
Average target price
128.55USD
Spread / Average Target
+1.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CSL Stock
  4. Financials CSL Limited